Greg Koblentz, member of the Center’s Scientists Working Group of Chemical and Biological Threats, spoke with the New York Times about the government oversight over dangerous pathogens.
“If the government implements the spirit of what they’ve written, this would be a major overhaul of dual-use research oversight in the United States,” said Gregory Koblentz, a biodefense specialist at George Mason University, referring to research that could also be used to do harm.
Still, he said, the White House should go beyond the board’s recommendations in creating an independent agency to perform that oversight, streamlining a system he considered too fragmentary.” Read more
